Patents by Inventor Neil C. Corley

Neil C. Corley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nek1-related protein kinase
    Patent number: 6713060
    Abstract: The invention provides a human Nek1-related protein kinase (NRPK) and polynucleotides which identify and encode NRPK. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of NRPK.
    Type: Grant
    Filed: January 11, 2000
    Date of Patent: March 30, 2004
    Assignee: Incyte Corporation
    Inventors: Olga Bandman, Neil C. Corley, Karl J. Guegler, Mariah Baughn
  • Human E1-like protein
    Publication number: 20040038279
    Abstract: The invention provides a human E1-like protein (HELPR) and polynucleotides which identify and encode HELPR. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HELPR.
    Type: Application
    Filed: July 21, 2003
    Publication date: February 26, 2004
    Applicant: Incyte Corporation
    Inventors: Preeti Lal, Neil C. Corley, Henry Yue
  • T-CELL RECEPTOR BETA-LIKE PROTEIN
    Publication number: 20040037839
    Abstract: The invention provides a human T-cell receptor beta-like protein (TCRLP) and polynucleotides which identify and encode TCRLP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of TCRLP.
    Type: Application
    Filed: September 27, 1999
    Publication date: February 26, 2004
    Inventors: JENNIFER L. HILLMAN, NEIL C. CORLEY
  • Humanena/VASP-like protein splice variant
    Publication number: 20040013670
    Abstract: The invention provides a human ena/VASP-like protein splice variant (EVL1) and polynucleotides which identify and encode EVL1. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of EVL1.
    Type: Application
    Filed: July 10, 2003
    Publication date: January 22, 2004
    Applicant: Incyte Corporation
    Inventors: Preeti Lal, Karl J. Guegler, Neil C. Corley
  • Antibodies to human goose-type lysozyme
    Patent number: 6660485
    Abstract: The invention provides a human goose-type lysozyme (GOLY) and polynucleotides which identify and encode GOLY. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of GOLY.
    Type: Grant
    Filed: April 26, 2001
    Date of Patent: December 9, 2003
    Assignee: Incyte Corporation
    Inventors: Preeti Lal, Karl J. Guegler, Neil C. Corley, Chandra Patterson
  • Maternally transcribed protein
    Publication number: 20030216311
    Abstract: The invention provides a human maternally transcribed protein (HMTP) and polynucleotides which identify and encode HMTP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of HMTP.
    Type: Application
    Filed: January 9, 2003
    Publication date: November 20, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Preeti Lal, Neil C. Corley
  • Human galactosyltranferases
    Patent number: 6649737
    Abstract: The invention provides human galactosyltransferases (HUGA) and polynucleotides which identify and encode HUGA. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HUGA.
    Type: Grant
    Filed: August 12, 1999
    Date of Patent: November 18, 2003
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Karl J. Guegler, Neil C. Corley, Purvi Shah, Chandra Patterson
  • Human ena/VASP-like protein splice variant
    Patent number: 6645499
    Abstract: The invention provides a human ena/VASP-like protein splice variant (EVL1) and polynucleotides which identify and encode EVL1. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of EVL1.
    Type: Grant
    Filed: September 1, 1999
    Date of Patent: November 11, 2003
    Assignee: Incyte Corporation
    Inventors: Preeti Lal, Karl J. Guegler, Neil C. Corley
  • Kinesin-like motor protein
    Publication number: 20030207318
    Abstract: The invention provides a human kinesin-like motor protein (KLIMP) and polynucleotides which identify and encode KLIMP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of KLIMP.
    Type: Application
    Filed: June 9, 2003
    Publication date: November 6, 2003
    Applicant: Incyte Corporation
    Inventors: Y. Tom Tang, Neil C. Corley, Karl J. Guegler, Chandra Patterson
  • Human galactosyltransferases
    Publication number: 20030203396
    Abstract: The invention provides human galactosyltransferases (HUGA) and polynucleotides which identify and encode HUGA. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HUGA.
    Type: Application
    Filed: June 10, 2003
    Publication date: October 30, 2003
    Applicant: Incyte Corporation
    Inventors: Jennifer L. Hillman, Karl J. Guegler, Neil C. Corley, Purvi Shah, Chandra Patterson
  • Tumor-associated antigen
    Patent number: 6632617
    Abstract: The invention provides a cDNA which encodes a TUAN. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of inflammatory and cell proliferative disorders, in particular, Crohn's disease and colon cancer. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.
    Type: Grant
    Filed: May 14, 2001
    Date of Patent: October 14, 2003
    Assignee: Incyte Corporation
    Inventors: Olga Bandman, Surya K. Goli, Purvi Shah, Neil C. Corley, David G. Streeter
  • Human proteinase molecules
    Patent number: 6627605
    Abstract: The invention provides human proteinase molecules, the polynucleotides which encode them, and methods for their use. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention further provides methods for diagnosing or treating disorders associated with expression of HPRM.
    Type: Grant
    Filed: March 8, 2001
    Date of Patent: September 30, 2003
    Assignee: Incyte Corporation
    Inventors: Olga Bandman, Neil C. Corley, Karl J. Guegler, Mariah R. Baughn
  • Insulin receptor tyrosine kinase substrate
    Publication number: 20030180810
    Abstract: The invention provides a human insulin receptor tyrosine kinase substrate (IRS-p53h) and polynucleotides which identify and encode IRS-p53h. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of IRS-p53h.
    Type: Application
    Filed: May 9, 2003
    Publication date: September 25, 2003
    Applicant: Incyte Corporation
    Inventors: Jennifer L. Hillman, Neil C. Corley, Karl J. Guegler, Mariah R. Baughn
  • Human transferase proteins
    Publication number: 20030175923
    Abstract: The invention provides human human transferase proteins (TRNSFS) and polynucleotides which identify and encode TRNSFS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of TRNSFS.
    Type: Application
    Filed: April 29, 2003
    Publication date: September 18, 2003
    Applicant: Incyte Corporation
    Inventors: Y. Tom Tang, Neil C. Corley, Karl J. Guegler, Mariah R. Baughn, Preeti G. Lal, Henry Yue, Jennifer L. Hillman, Yalda Azimzai
  • Human lysophosphatidic acid acyltransferase
    Publication number: 20030175924
    Abstract: The invention provides a human lysophosphatidic acid acyltranferase (HLPAAT) and polynucleotides which identify and encode HLPAAT. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HLPAAT.
    Type: Application
    Filed: May 5, 2003
    Publication date: September 18, 2003
    Applicant: Incyte Corporation
    Inventors: Jennifer L. Hillman, Henry Yue, Karl J. Guegler, Neil C. Corley
  • Human SMN-like protein
    Patent number: 6620783
    Abstract: The invention provides a human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HSLP.
    Type: Grant
    Filed: May 15, 2000
    Date of Patent: September 16, 2003
    Assignee: Incyte Corporation
    Inventors: Y. Tom Tang, Neil C. Corley, Karl J. Guegler
  • Human cathepsin
    Patent number: 6620606
    Abstract: The invention provides a new human cathepsin (LCAP) and polynucleotides which identify and encode LCAP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of LCAP.
    Type: Grant
    Filed: March 7, 2000
    Date of Patent: September 16, 2003
    Assignee: Incyte Corporation
    Inventors: Olga Bandman, Karl J. Guegler, Neil C. Corley, Purvi Shah
  • Disease associated protein kinases
    Publication number: 20030170219
    Abstract: The invention provides human disease associated protein kinases and polynucleotides (collectively designated DAPK) which identify and encode them. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention further provides methods for diagnosing and treating disorders associated with expression of human disease associated protein kinases.
    Type: Application
    Filed: January 24, 2001
    Publication date: September 11, 2003
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Jennifer L. Hillman, Neil C. Corley, Karl J. Guegler, Preeti Lal, Surya K. Goli, Purvi Shah
  • Serine dehydratase homolog
    Publication number: 20030166199
    Abstract: The invention provides a human serine dehydratase homolog (SDHH) and polynucleotides which identify and encode SDHH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of SDHH.
    Type: Application
    Filed: August 8, 2001
    Publication date: September 4, 2003
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Preeti Lal, Neil C. Corley, Karl J. Guegler, Chandra Patterson
  • Human E1-like protein
    Patent number: 6610526
    Abstract: The invention provides a human E1-like protein (HELPR) and polynucleotides which identify and encode HELPR. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HELPR.
    Type: Grant
    Filed: March 13, 1998
    Date of Patent: August 26, 2003
    Assignee: Inctye Corporation
    Inventors: Preeti Lal, Neil C. Corley, Henry Yue